Urticaria is not a sentence. The clinical cases | Zendy

I V Danilycheva | Zendy; A E Shulzhenko | Zendy; N G Bondarenko | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Urticaria is not a sentence. The clinical cases

Author(s) -

I V Danilycheva,

A E Shulzhenko,

N G Bondarenko

Publication year - 2016

Publication title -

russian journal of allergy

Language(s) - English

Resource type - Journals

eISSN - 2686-682X

pISSN - 1810-8830

DOI - 10.36691/rja374

Subject(s) - omalizumab , medicine , refractory (planetary science) , immunoglobulin e , monoclonal antibody , chronic urticaria , dermatology , monoclonal , immunology , antibody , biology , astrobiology

Omalizumab - monoclonal therapeutic antibody to human IgE, is effectively used for the treatment of patients with chronic spontaneous urticaria (HSC), refractory to 4 times increased doses of antihistamines. The article describes two cases of effective treatment of patients (HSC) with omalizumab (Xolair® «Novartis Pharma» LLC) after a long period of unsuccessful therapy with H1-antihistamines, leukotriene receptor antagonists, and corticosteroids.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research